European Stock exchanges jump eyeing COVID-19 vaccine developments

Following a rout in technology stocks on Wall Street that subdued global investor sentiments, on Monday, European shares rebounded with investors keeping a close eye on COVID-19 vaccine developments.

Australia is likely to receive its first batches of a potential COVID-19 vaccine in January 2021 after striking a manufacturing deal with CSL, which will make two vaccines – one developed by AstraZeneca and the other by Oxford University.

With the news reaching the market, AstraZeneca’s shares rose by 1.5%.

The European healthcare sector index also rose by 0.9%.

At 0709 GMT, the STOXX 600 index also jumped by 0.8%.

Shares of insurance companies, automakers and banks rose by 1% in early trading.

Categories: Creativity, Economy & Finance, Entrepreneurship, HR & Organization, Strategy

Tags: , , , , , , , , , , , , , , , , , , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: